HNRNPL and prostate carcinoma: In prostate cancer, PD-L1 was positively related to heterogeneous nuclear ribonucleoprotein L (HnRNPL) [176], which overexpressed and consequently enhanced the mRNA stability of YY1, in turn generating pro-proliferative and anti-apoptotic effects [177].